These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 25349217)
21. Trifluoperazine Inhibits Mesangial Cell Proliferation by Arresting Cell Cycle-Dependent Mechanisms. Wang B; Zhou X; Wang Y; Li R Med Sci Monit; 2017 Jul; 23():3461-3469. PubMed ID: 28713151 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy. Lin CY; Ku FM; Kuo YC; Chen CF; Chen WP; Chen A; Shiao MS J Lab Clin Med; 1999 Jan; 133(1):55-63. PubMed ID: 10385482 [TBL] [Abstract][Full Text] [Related]
23. Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability. Pallet N; Thervet E; Le Corre D; Knebelmann B; Nusbaum P; Tomkiewicz C; Meria P; Flinois JP; Beaune P; Legendre C; Anglicheau D Kidney Int; 2005 Jun; 67(6):2422-33. PubMed ID: 15882288 [TBL] [Abstract][Full Text] [Related]
24. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067 [TBL] [Abstract][Full Text] [Related]
25. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms. Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829 [TBL] [Abstract][Full Text] [Related]
26. Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion. Zhu X; Shen X; Lin B; Fang J; Jin J; He Q Front Pharmacol; 2022; 13():889008. PubMed ID: 35899112 [No Abstract] [Full Text] [Related]
27. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379 [TBL] [Abstract][Full Text] [Related]
28. EIF2α/ATF4 pathway enhances proliferation of mesangial cell via cyclin D1 during endoplasmic reticulum stress in IgA nephropathy. Lan Z; Zhao L; Peng L; Wan L; Liu D; Tang C; Chen G; Liu Y; Liu H Clin Immunol; 2023 Dec; 257():109840. PubMed ID: 37939913 [TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats. Bai L; Li H; Li J; Song J; Zhou Y; Liu B; Lu R; Zhang P; Chen J; Chen D; Pang Y; Liu X; Wu J; Liang C; Zhou J Int Immunopharmacol; 2019 May; 70():313-323. PubMed ID: 30852287 [TBL] [Abstract][Full Text] [Related]
30. Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-κB/AP-1 pathways. Lan T; Wu T; Chen C; Chen X; Hao J; Huang J; Wang L; Huang H Mol Cell Endocrinol; 2014 Mar; 384(1-2):109-16. PubMed ID: 24508662 [TBL] [Abstract][Full Text] [Related]
31. Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney. Sawai K; Mukoyama M; Mori K; Kasahara M; Koshikawa M; Yokoi H; Yoshioka T; Ogawa Y; Sugawara A; Nishiyama H; Yamada S; Kuwahara T; Saleem MA; Shiota K; Ogawa O; Miyazato M; Kangawa K; Nakao K Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1363-72. PubMed ID: 17699553 [TBL] [Abstract][Full Text] [Related]
32. Effect of immunosuppression on the human mesangial cell cycle. Zhou X; Workeneh B; Hu Z; Li R Mol Med Rep; 2015 Feb; 11(2):910-6. PubMed ID: 25370945 [TBL] [Abstract][Full Text] [Related]
33. [Effect of saikosaponin-d on rat's glomerular mesangial cell proliferation and extracellular matrix hyperplasia in vitro]. Zu N; Dong X; Fu GX Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Apr; 27(4):321-5. PubMed ID: 17526171 [TBL] [Abstract][Full Text] [Related]
34. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. Bonegio RG; Fuhro R; Wang Z; Valeri CR; Andry C; Salant DJ; Lieberthal W J Am Soc Nephrol; 2005 Jul; 16(7):2063-72. PubMed ID: 15917339 [TBL] [Abstract][Full Text] [Related]
35. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat. Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032 [TBL] [Abstract][Full Text] [Related]
36. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression. Lu X; Fan Q; Xu L; Li L; Yue Y; Xu Y; Su Y; Zhang D; Wang L PLoS One; 2015; 10(2):e0117400. PubMed ID: 25689721 [TBL] [Abstract][Full Text] [Related]
37. Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathy. Coombes JD; Mreich E; Liddle C; Rangan GK Kidney Int; 2005 Dec; 68(6):2599-607. PubMed ID: 16316336 [TBL] [Abstract][Full Text] [Related]
38. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [TBL] [Abstract][Full Text] [Related]
39. Rapamycin Induces Autophagy and Reduces the Apoptosis of Podocytes Under a Stimulated Condition of Immunoglobulin A Nephropathy. Liang S; Jin J; Lin B; Gong J; Li Y; He Q Kidney Blood Press Res; 2017; 42(1):177-187. PubMed ID: 28427080 [TBL] [Abstract][Full Text] [Related]
40. Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis. Gu L; Zhou C; Liu H; Gao J; Li Q; Mu D; Ma Z J Exp Clin Cancer Res; 2010 Nov; 29(1):150. PubMed ID: 21083937 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]